![Andrew Salzman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Salzman
Chief Tech/Sci/R&D Officer at
HINTO ENERGY, INC.
Profile
Andrew L.
Salzman was the founder of Inotek Pharmaceuticals Corp.
(1999) and Beetlebung Pharma Ltd. (2018), where he held the title of President & Chief Executive Officer and Chairman respectively.
Dr. Salzman is also the founder of Radikal Therapeutics, Inc., Tisbury Pharmaceuticals, Inc., Chilmark Labs, Inc. Dr. Salzman's current jobs include Chairman positions at Salzman Capital Ventures Ltd., Respirometics Ltd., and Salzman Lovelace Investments, as well as Chief Scientific Officer at Hinto Energy, Inc. starting in 2023.
Dr. Salzman's former jobs include CEO, Director & Chief Medical Officer at Claritas Pharmaceuticals, Inc., Director-Critical Care Division at Children's Hospital Medical Center of Akron, Director-Drug Development at Lovelace Respiratory Research Institute, and Director at RDD Pharma Ltd. Dr. Salzman's education includes an undergraduate degree from Yale University and a doctorate from Harvard Medical School.
Andrew Salzman active positions
| Companies | Position | Start |
|---|---|---|
| HINTO ENERGY, INC. | Chief Tech/Sci/R&D Officer | 2023-03-06 |
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative pharmaceuticals of bifunctional edox-based small molecules | Founder | - |
Salzman Capital Ventures Ltd. | Chairman | - |
Respirometics Ltd. | Chairman | - |
Salzman Lovelace Investments | Chairman | - |
Chilmark Labs, Inc.
 Chilmark Labs, Inc. Agricultural Commodities/MillingProcess Industries Processes cannabinoid products | Founder | - |
Beetlebung Pharma Ltd.
 Beetlebung Pharma Ltd. Pharmaceuticals: OtherHealth Technology Engages in pharmaceutical business based on cannabinoid products | Founder | 2018-03-19 |
Former positions of Andrew Salzman
| Companies | Position | End |
|---|---|---|
| INNOVATION1 BIOTECH INC. | Chief Tech/Sci/R&D Officer | 2022-11-10 |
| CLARITAS PHARMACEUTICALS, INC. | Chief Executive Officer | 2017-06-20 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Andrew Salzman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Hinto Energy, Inc.
 Hinto Energy, Inc. Integrated OilEnergy Minerals Operates as an oil and gas exploration and development company | Energy Minerals |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Children's Hospital Medical Center of Akron
 Children's Hospital Medical Center of Akron Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Lovelace Respiratory Research Institute
 Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Commercial Services |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology Develops pharmacological treatments for diseases of the anorectal region | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative pharmaceuticals of bifunctional edox-based small molecules | Commercial Services |
Salzman Capital Ventures Ltd. | |
Respirometics Ltd. | |
Claritas Pharmaceuticals, Inc.
 Claritas Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops and commercializes therapies for patients | Health Technology |
Salzman Lovelace Investments | |
Tisbury Pharmaceuticals, Inc.
 Tisbury Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage pharmaceutical company that discovers, develops and manufactures pharmaceutical drugs to treat primary open angle glaucoma | Commercial Services |
Innovation1 Biotech, Inc.
 Innovation1 Biotech, Inc. Internet RetailRetail Trade Sells consumer cannabidiol products through online | Retail Trade |
Chilmark Labs, Inc.
Chilmark Labs, Inc. Agricultural Commodities/MillingProcess Industries Processes cannabinoid products | Process Industries |
Beetlebung Pharma Ltd.
Beetlebung Pharma Ltd. Pharmaceuticals: OtherHealth Technology Engages in pharmaceutical business based on cannabinoid products | Health Technology |
- Stock Market
- Insiders
- Andrew Salzman
Choose MarketScreener 
